Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) conferred a greater risk reduction in all-cause mortality, despite inferior weight loss results when compared with bariatric surgery, researchers noted
Tens of thousands of licensed prescribers now routinely recommend compounded GLP-1 therapy, insurance companies acknowledge compounded peptide medications in their benefit analyses, and employers view compounded weight loss programs as cost-effective health interventions
Gastrointestinal Side Effects When Mixing Alcohol and Semaglutide The most common complaint from semaglutide patients who drink alcohol is worsening nausea and abdominal discomfort
Common Side Effects and Considerations for Weight Loss Medication Like all medications, GLP-1 agonists can have side effects
Insulin lowers it, while glucagon raises it by telling the liver to release stored sugar
No Phase 1, Phase 2, or observational human study exists at the time of writing